Arlington, MA, United States of America

Vincent Guerlavais

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 489(Granted Patents)


Location History:

  • Oakland, CA (US) (2009 - 2010)
  • Arlington, MA (US) (2013 - 2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovations in Peptidomimetics: The Contributions of Vincent Guerlavais

Introduction

Vincent Guerlavais, based in Arlington, MA, is a pioneering inventor renowned for his significant contributions to the field of pharmaceuticals with a remarkable portfolio of 22 patents. His innovative work primarily focuses on the development of peptidomimetic macrocycles, which exhibit vast potential in treating various medical conditions, including cancer.

Latest Patents

Among Vincent's latest patents is the invention of "Peptidomimetic macrocycles and uses thereof." This patent details the synthesis of peptidomimetic macrocycles and explores their applications in combination with other pharmaceutically-active agents. These macrocycles are designed to effectively treat various conditions, showcasing a novel approach to therapeutic solutions. His subsequent patent reiterates the development of these macrocycles and their applications in treating diseases, representing a crucial advancement in medicinal chemistry.

Career Highlights

Vincent has collaborated with some notable companies in the biotech industry, including Aileron Therapeutics, Inc. and Medarex Inc. His career trajectory reflects not only his dedication to research but also his impact on advancing therapeutic innovations. Through his extensive work, he has established himself as a leader in developing new methods for drug discovery and delivery.

Collaborations

In his professional journey, Vincent has had the opportunity to work alongside esteemed colleagues such as Noriyuki Kawahata and Eric Feyfant. These collaborations have facilitated the exchange of ideas and fostered innovation, further enhancing the potential of peptidomimetic therapies.

Conclusion

Vincent Guerlavais stands out as a significant figure in the realm of pharmaceutical innovations. His 22 patents, particularly in the area of peptidomimetic macrocycles, underscore his commitment to developing effective treatments for pressing medical conditions. With his collaborative spirit and innovative mindset, Vincent continues to make influential contributions to the field of drug discovery and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…